DETERMINATION AND CLINICAL SIGNIFICANCE OF BONE PSEUDOPROGRESSION IN HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER

被引：0
|
作者：
Zhang, Jian [1 ]
Lin, Mingxi [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
BREAST | 2021年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO72
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [21] Prognostic significance of estrogen receptor in hormone receptor-positive and HER2-positive breast cancer
    Hikichi, M.
    Ushimado, K.
    Ri, Y.
    Kobayashi, N.
    Utsumi, T.
    BREAST, 2017, 32 : S94 - S95
  • [22] Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab
    Magbanua, Mark Jesus M.
    Savenkov, Oleksandr
    Asmus, Erik J.
    Ballman, Karla V.
    Scott, Janet H.
    Park, John W.
    Dickler, Maura
    Partridge, Ann
    Carey, Lisa A.
    Winer, Eric P.
    Rugo, Hope S.
    CLINICAL CANCER RESEARCH, 2020, 26 (18) : 4911 - 4920
  • [23] ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
    Brett, Jamie O.
    Spring, Laura M.
    Bardia, Aditya
    Wander, Seth A.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [24] Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
    Carvajal-Hausdorf, Daniel E.
    Mani, Nikita
    Velcheti, Vamsidhar
    Schalper, Kurt A.
    Rimm, David L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [25] The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
    Bielo, Luca Boscolo
    Trapani, Dario
    Nicolo, Eleonora
    Valenza, Carmine
    Guidi, Lorenzo
    Belli, Carmen
    Kotteas, Elias
    Marra, Antonio
    Prat, Aleix
    Fusco, Nicola
    Criscitiello, Carmen
    Burstein, Harold J.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2024, 128
  • [26] A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer
    Magno, Elizabeth
    Bussard, Karen M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [27] Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer
    Wander, Seth A.
    Spring, Laura M.
    Bardia, Aditya
    LANCET ONCOLOGY, 2019, 20 (06): : 746 - 748
  • [28] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ahrong Ham
    Min Hwan Kim
    Gun Min Kim
    Jee Hung Kim
    Jee Ye Kim
    Hyung Seok Park
    Seho Park
    Young Up Cho
    Byeong Woo Park
    Seung Il Kim
    Joohyuk Sohn
    Breast Cancer Research and Treatment, 2020, 183 : 107 - 116
  • [29] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    中华医学杂志英文版, 2020, 133 (19) : 2338 - 2345
12345